-
Document de presse | 2012.11.13
The Institut Pasteur inaugurates its new center for research on emerging diseases at a ceremony attended by French President François Hollande
On November 14, 2012, Professor Alice Dautry, President of the Institut Pasteur, and Jean-Pierre Jouyet, Chairman of the Institut Pasteur Board of Directors, officially opened the Institut Pasteur’s research center for the study of emerging diseases at a ceremony attended by French President François Hollande. Paris, november 14, 2013 In recent decades, we have witnessed...
-
Document de presse | 2012.09.13
Institut Pasteur and WHO join forces in the fight against epidemics
On Thursday September 13, in Geneva, the Institut Pasteur and the World Health Organisation (WHO) signed a cooperation agreement concerning the response to epidemics and worldwide health safety. Their aim is to help countries to strengthen their capacities for surveillance, detection and response in application of the International Health Regulations drawn up by WHO. Press release Paris,...
-
Document de presse | 2009.08.24
Whooping cough: increase in vaccine coverage, decrease in bacterial virulence
The whooping cough monitoring carried out in France has enabled Institut Pasteur and CNRS researchers to analyze Bordetella pertussis, the bacterium responsible for whooping cough. For the first time, among the strains in circulation, they have identified bacteria not expressing some of the virulence factors targeted by the vaccine, such as the bacterial toxin. These observations confirm the...
-
Document de presse | 2005.01.19
The Institut Pasteur retains its rights on an innovative patent
The European Patent Office has confirmed the Institut Pasteur in its rights over an important technology, based on an innovative use of homologous recombination. The European patent, granted as no. 419621, was licensed to the Institut Pasteur's spin-off company, Cellectis. It covers applications in the areas of production of recombinant proteins, gene therapy, and the production of animal...
-
Document de presse | 2004.01.28
France/China : Real cooperation in the field of infectious diseases with the plan for an Institut Pasteur in China
Within the context of French-Chinese cooperation, which has expanded on the occasion of President Hu Jintao's state visit, health is one of the most important sectors. A declaration of intent on the prevention of and fight against emerging infectious diseases was signed yesterday at Matignon by Ms. Claudie Haigneré and Jean François Mattei, and Mr. Yan Hua Liu, deputy minister of Science and...
-
Document de presse | 2004.01.20
World Leprosy Day (25 January): The Institut Pasteur develops new diagnostic testsand epidemiological tools
According to the World Health Organisation, 2.8 million people throughout the world are infected with leprosy, and each year about 750,000 new cases are recorded. Since the leprosy bacillus genome was sequenced in 2001 by the team directed by Stewart Cole of the Institut Pasteur , important advances have been made. New diagnostic tests and epidemiological tools are currently being developed in...
-
Article | 2016.11.15
Charles Nicolle (1866-1936)
In 1928 Charles Nicolle won the Nobel Prize in Medicine for his work on typhus. He notably discovered the role of lice in transmission of the infection in humans.
-
Article | 2016.12.21
Dedonder Clayton Award
The Dedonder Clayton Award honors scientists in Africa and Asia whose outstanding research is decisive to progress in public health, specifically in the field of research on HIV / AIDS and related infections.
-
Article | 2017.03.17
Fundraising for the Institut Pasteur
Did you know that fundraising can be a team effort? This can be a great way of sharing your commitment to funding medical research with others. Read on to find out how you can coordinate a fundraising scheme for the Institut Pasteur.
-
Article | 2017.03.27
In return for your support
Being a partner of the Institut Pasteur means benefiting from the image of an internationally renowned foundation that is widely recognized for its scientific excellence in the field of health. It can also provide you with a number of specific privileges in return for your support.